Observational studyJournal of medical virology2022

Elevated inflammatory markers are associated with poor outcomes in COVID-19 patients treated with remdesivir.

Kate Stoeckle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.